Comparison between Agilus Diagnostics IPO and Kanodia Cement IPO.
Agilus Diagnostics IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Kanodia Cement IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Agilus Diagnostics IPO is up to ₹0.00 Cr whereas the issue size of the Kanodia Cement IPO is up to ₹0.00 Cr. The final issue price of Agilus Diagnostics IPO is and of Kanodia Cement IPO is .
| Agilus Diagnostics IPO | Kanodia Cement IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 1,42,33,964 shares | 1,49,13,930 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 1,42,33,964 shares | 1,49,13,930 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Agilus Diagnostics IPO opens on , while Kanodia Cement IPO opens on . The closing date of Agilus Diagnostics IPO and Kanodia Cement IPO is , and , respectively.
Agilus Diagnostics IPO P/E ratio is , as compared to Kanodia Cement IPO P/E ratio of .
| Agilus Diagnostics IPO | Kanodia Cement IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 57.68 | 91.99 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 6.12 | 33.58 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 20.17 | 36.47 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | -0.23 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹15.27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 6.61 | 33.16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Agilus Diagnostics IPO Retail Individual Investors (RII) are offered 0 shares while in Kanodia Cement IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Agilus Diagnostics IPO and 0 shares in Kanodia Cement IPO.
| Agilus Diagnostics IPO | Kanodia Cement IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Agilus Diagnostics IPO subscribed in total, whereas Kanodia Cement IPO subscribed .
